Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV.

@article{Drossman2016FunctionalGD,
  title={Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV.},
  author={Douglas A. Drossman},
  journal={Gastroenterology},
  year={2016}
}
  • D. Drossman
  • Published 1 May 2016
  • Medicine
  • Gastroenterology
Functional gastrointestinal disorders (FGIDs), the most common diagnoses in gastroenterology are recognized by morphological and physiological abnormalities that often occur in combination including motility disturbance, visceral hypersensitivity, altered mucosal and immune function, altered gut microbiota and altered central nervous system processing. Research on these gut-brain interaction disorders is based on using specific diagnostic criteria. The Rome Foundation has played a pivotal role… 
Using the Rome IV Criteria to Help Manage the Complex IBS Patient
TLDR
A complex IBS patient is discussed using an algorithmic multidimensional clinical profi le (MDCP) approach that can be applied to each FGID patient, to help clinicians assess clinical modifi ers and individualize treatment.
The Rome IV: Irritable bowel syndrome - A functional disorder.
TLDR
The Rome IV consensus is a robust standard for a clinical and research approach to functional gastrointestinal disorders, but might be improved by use of exclusion criteria and additional biochemical biomarkers in order to accurately diagnose those patients who may achieve relief by an extended treatment approach in the clinical setting of gastroenterology.
Functional gastrointestinal disorders: advances in understanding and management
TLDR
Symptom-based criteria are used to make a diagnosis, with judicious use of limited investigations in some patients, and the general principles of treatment are based on a biopsychosocial understanding and involve management of physical symptoms and, if present, psychological comorbidity.
What Is New in Rome IV
TLDR
The aim is to review the main changes in Rome IV, which has a multicultural rather than a Western-culture focus, and new FGIDs based on available evidence including reflux hypersensitivity and centrally mediated abdominal pain syndrome.
Physiological mechanisms of unexplained (functional) gastrointestinal disorders
TLDR
Considerations for future research should include the role of sex hormones in regulating physiological functions and treatment responses in patients, as well as the importance of high‐level phenotyping of clinical, immune, microbial and physiological parameters in study cohorts.
How to use Rome IV criteria in the evaluation of esophageal disorders
  • M. Schmulson
  • Medicine
    Current opinion in gastroenterology
  • 2018
TLDR
The Rome IV criteria for esphageal DGBI, the updated algorithms for esophageal symptoms, and the multidimensional clinical profile (MDCP) are reviewed.
Functional Abdominal Pain
TLDR
FGIDs are now defined as disorders of brain–gut interaction, and effective management requires a biopsychosocial approach that addresses the variability and complexity of these patients.
Gut Inflammation: More Than a Peripheral Annoyance
TLDR
A preclinical model of neonatal colon inflammation is utilized to examine symptoms or functions central to functional dyspepsia, specifically early satiety, discomfort, delayed gastric empting, and anxietyand depression-like behaviors.
Tangible pathologies in functional dyspepsia.
TLDR
Most therapies for FD are inadequate but underlying pathology may lead to targeted treatment success as an attainable goal, and triggers of this condition based on epidemiology studies point towards allergy, immune disorders and infection.
Management of functional gastrointestinal disorders in children. Focus on restoring intestinal microenvironment and motility
TLDR
Trimebutine is included in the Russian guidelines for the diagnosis and treatment of functional disorders of the digestive tract in children, as well as in the clinical guidelines forThe treatment of irritable bowel syndrome, functional dyspepsia, and functional abdominal pain.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 98 REFERENCES
Rome II: the Functional Gastrointestinal Disorders. Diagnosis, Pathophysiology and Treatment: a Multinational Consensus
TLDR
The Rome process has had a major impact, and Rome criteria are now used for the entry into most clinical trials, so that classifications must of necessity be symptom based.
Intestinal microbiota in functional bowel disorders: a Rome foundation report
TLDR
A critical review of current hypotheses regarding the pathogenetic involvement of microbiota in FGID is provided and the results of microbiota-directed interventions are evaluated and clinical guidance on modulation of gut microbiota in IBS is provided.
The Role of Food in the Functional Gastrointestinal Disorders: Introduction to a Manuscript Series
  • W. Chey
  • Medicine
    The American Journal of Gastroenterology
  • 2013
TLDR
In a series of evidence-based manuscripts produced by the Rome Foundation Working Group on the role of food in FGIDs, comprehensive reviews of the physiological changes associated with nutrient intake, and the respective roles of carbohydrates, fiber, protein, and fats are provided.
Functional bowel disorders and functional abdominal pain
TLDR
A committee consensus approach, including criticism from multinational expert reviewers, was used to revise the diagnostic criteria and update diagnosis and treatment recommendations, based on research results.
Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions
TLDR
Functional and anatomical evidence for abnormal neuroimmune interactions has been found in patients with IBS and the link between immune alterations and severity of gastrointestinal symptoms and the positive effect of anti-inflammatory treatments in IBS further highlight the relevance of neuro immune interactions in this condition.
Genetic approaches to functional gastrointestinal disorders.
TLDR
A better understanding of the genetic architecture of functional gastrointestinal disorders would help to better identify their complex biology and explain the common comorbidity with other disorders of persistent pain, mood, and affect, as well as possibly make it possible to identify subgroups of patients who respond to customized therapies.
The functional gastrointestinal disorders and the Rome III process.
TLDR
Two important processes have occurred to legitimize these conditions, and to increase attention toward the research and clinical care of patients with functional gastrointestinal disorders (FGID), a shift in conceptualizing these disorders from a disease-based, reductionistic model, to a more integrated, biopsychosocial model of illness.
Dietary Proteins and Functional Gastrointestinal Disorders
TLDR
The role of dietary proteins in the symptoms and pathophysiology of FGIDs is summarized, which suggests a heterogeneous condition with some features of celiac disease but often categorized as FGIDs, including IBS.
Basic and clinical aspects of visceral hyperalgesia.
TLDR
A model is proposed by which abdominal pain from chronic inflammatory conditions of the gut and functional bowel disorders such as noncardiac chest pain, nonulcer dyspepsia, and irritable bowel syndrome could develop by multiple mechanisms either alone or in combination.
Dietary Lipids and Functional Gastrointestinal Disorders
TLDR
Large studies are needed to evaluate dietary patterns and eating behavior in patients with functional gastrointestinal disorders, with often-conflicting outcomes, and the role of targeted dietary interventions for the relief of symptoms to develop personalized, cost-effective treatment approaches.
...
1
2
3
4
5
...